Literature DB >> 18445375

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.

A Lackenby1, O Hungnes, S G Dudman, A Meijer, W J Paget, A J Hay, M C Zambon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18445375     DOI： 10.2807/ese.13.05.08026-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


× No keyword cloud information.
  120 in total

Review 1.  Methods for molecular surveillance of influenza.

Authors:  Ruixue Wang; Jeffery K Taubenberger
Journal:  Expert Rev Anti Infect Ther       Date:  2010-05       Impact factor: 5.091

Review 2.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

3.  High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity.

Authors:  Ching-Yao Su; Ting-Jen R Cheng; Meng-I Lin; Shi-Yun Wang; Wen-I Huang; Shao-Ying Lin-Chu; Yu-Hou Chen; Chung-Yi Wu; Michael M C Lai; Wei-Chieh Cheng; Ying-Ta Wu; Ming-Daw Tsai; Yih-Shyun E Cheng; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 4.  Influenza.

Authors:  Tom Jefferson
Journal:  BMJ Clin Evid       Date:  2009-03-12

5.  Whole genome sequencing identifies influenza A H3N2 transmission and offers superior resolution to classical typing methods.

Authors:  Dominik M Meinel; Susanne Heinzinger; Ute Eberle; Nikolaus Ackermann; Katharina Schönberger; Andreas Sing
Journal:  Infection       Date:  2017-10-31       Impact factor: 3.553

6.  In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Authors:  Katrina Sleeman; Vasiliy P Mishin; Varough M Deyde; Yousuke Furuta; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

7.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

8.  Novel swine-origin influenza A (H1N1) virus-associated hemophagocytic syndrome--a first case report.

Authors:  Yishan Zheng; Yongfeng Yang; Wei Zhao; Hong Wang
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

9.  Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds.

Authors:  Alex B Kleinpeter; Alexander S Jureka; Sally M Falahat; Todd J Green; Chad M Petit
Journal:  J Biol Chem       Date:  2018-08-03       Impact factor: 5.157

10.  CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.

Authors:  Makoto Yamashita; Takanori Tomozawa; Masayo Kakuta; Akane Tokumitsu; Hatsumi Nasu; Shuku Kubo
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.